EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease

Rebecca T Brooks, Brent Luedders iD, Austin Wheeler iD, Tate M Johnson iD, Yangyuna Yang, Punyasha Roul, Apar Kishor Ganti iD, Namrata Singh, Brian C Sauer iD, Grant W Cannon iD, Joshua F Baker iD, Ted R Mikuls iD und 1 weitere

Arthritis & Rheumatology · 2024-12 · 76 (12) · 1730-1738

DOI: 10.1002/art.42961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 16.08.2024. Verfasst von Rebecca T Brooks und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Lung Diseases, Interstitial, Lung Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Great Plains IDeA-CTR Network, VA BLRD, VA Clinical Science Research and Development (CSRD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to evaluate lung cancer risk in patients with rheumatoid arthritis (RA) and RA‐interstitial lung disease (ILD).

Methods

We performed a retrospective, matched cohort study of RA and RA‐ILD within the Veterans Health Administration (VA) between 2000 and 2019. Patients with RA and RA‐ILD were identified with validated administrative‐based algorithms, then matched (up to 1:10) on age, gender, and VA enrollment year to individuals without RA. Lung cancers were identified from a VA oncology database and the National Death Index. Conditional Cox regression models assessed lung cancer risk adjusting for race, ethnicity, smoking status, Agent Orange exposure, and comorbidity burden among matched individuals. Several sensitivity analyses were performed.

Results

We matched 72,795 patients with RA with 633,937 patients without RA (mean age 63 years; 88% male). Over 4,481,323 patient‐years, 17,099 incident lung cancers occurred. RA was independently associated with an increased lung cancer risk (adjusted hazard ratio [aHR] 1.58 [95% confidence interval (CI) 1.52–1.64]), which persisted in never smokers (aHR 1.65 [95% CI 1.22–2.24]) and in those with incident RA (aHR 1.54 [95% CI 1.44–1.65]). Compared to non‐RA controls, prevalent RA‐ILD (n = 757) was more strongly associated with lung cancer risk (aHR 3.25 [95% CI 2.13–4.95]) than RA without ILD (aHR 1.57 [95% CI 1.51–1.64]). Analyses of both prevalent and incident RA‐ILD produced similar results (RA‐ILD vs non‐RA aHR 2.88 [95% CI 2.45–3.40]).

Conclusion

RA was associated with a >50% increased risk of lung cancer, and those with RA‐ILD represented a particularly high‐risk group with an approximate three‐fold increased risk. Increased lung cancer surveillance in RA, and especially RA‐ILD, may be a useful strategy for reducing the burden posed by the leading cause of cancer death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidLung Diseases, InterstitialLung NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedUnited StatesRisk FactorsIncidenceProportional Hazards Models

Autor:innen und Institutionen

  • Mayo Clinic, Rochester, Minnesota.
  • The Department of Veterans Affairs Nebraska-Western Iowa Health Care System and the University of Nebraska Medical Center, Omaha.
  • University of Washington, Seattle.
  • Salt Lake City Department of Veterans Affairs and the University of Utah.
  • Corporal Michael J. Crescenz Department of Veterans Affairs and the University of Pennsylvania, Philadelphia.

ORCID-Profile: Brent Luedders, Austin Wheeler, Tate M Johnson, Apar Kishor Ganti, Brian C Sauer, Grant W Cannon, Joshua F Baker, Ted R Mikuls, Bryant R England

Förderung

  • Great Plains IDeA-CTR Network
  • VA BLRD
  • VA Clinical Science Research and Development (CSRD)
  • CSRD VA
  • American Heart Association
  • RRD VA
  • Department of Defense
  • NIGMS NIH HHS

Zitieren

APA

Brooks, R. T., Luedders, B., Wheeler, A., Johnson, T. M., Yang, Y., Roul, P., Ganti, A. K., Singh, N., Sauer, B. C., Cannon, G. W., Baker, J. F., Mikuls, T. R., & England, B. R. (2024). The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease. Arthritis & Rheumatology, 76(12), 1730-1738. https://doi.org/10.1002/art.42961

Vancouver

Brooks RT, Luedders B, Wheeler A, Johnson TM, Yang Y, Roul P, et al. The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease. Arthritis & Rheumatology. 2024;76(12):1730-1738. doi:10.1002/art.42961

BibTeX
@article{Brooks2024,
  author = {Brooks, Rebecca T and Luedders, Brent and Wheeler, Austin and Johnson, Tate M and Yang, Yangyuna and Roul, Punyasha and Ganti, Apar Kishor and Singh, Namrata and Sauer, Brian C and Cannon, Grant W and Baker, Joshua F and Mikuls, Ted R and England, Bryant R},
  title = {The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  volume = {76},
  number = {12},
  pages = {1730--1738},
  doi = {10.1002/art.42961}
}
Kostenlos starten →